The Patent Finder

Terms ending in 2041

Juno, Inc.

Every in-force patent on Juno, Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,851,678Methods for Producing Genetically Engineered Cell Compositions and Related Compositions
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US 12,006,356ANTI-CCT5 Binding Molecules and Chimeric Antigen Receptors Comprising the Same
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US 11,471,489T Cell Receptors and Engineered Cells Expressing Same
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US D1,124,358Menstrual Pain Management Device
In force
 · High confidence
Juno Technologies Inc.In forceHigh confidence
US 12,163,952Determining Toxicity Risk in CAR T-Cell Therapy
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
US 12,268,741Antibodies and Chimeric Antigen Receptors Specific for Receptor Tyrosine Kinase Like Orphan Receptor 1 (ROR1)
In force
 · High confidence
Juno Therapeutics, Inc.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited